Evidence map›Paper›PMID 42882116›Full record

ReviewJournal of clinical medicine2026

Novel

Federico Pieruzzi, Renzo Mignani, Sandro Feriozzi, Marialuisa Zedde, Gianni Carraro, Cristina Chimenti, Antonio Pisani, Marco Spada, Amelia Morrone

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Federico PieruzziNephrology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.ORCID 0000-0002-1302-6846
Renzo MignaniDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.ORCID 0000-0001-8507-8939
Sandro FeriozziNephrology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.ORCID 0000-0001-8420-8447
Marialuisa ZeddeNeurology Unit, Stroke Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.ORCID 0000-0001-7530-818X
Gianni CarraroNephrology, Dialysis and Transplant Unit, Department of Medicine, Padova University Hospital, 35128 Padova, Italy.
Cristina ChimentiDepartment of Medical and Cardiovascular Sciences, La Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-5954-3796
Antonio PisaniDepartment of Public Health, Federico II University of Naples, 80138 Naples, Italy.
Marco SpadaDepartment of Pediatrics, University of Turin, 10124 Torino, Italy.ORCID 0000-0002-8894-350X
Amelia MorroneLaboratory of Molecular Genetics of Neurometabolic Diseases, Department of Neuroscience and Human Genetics, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing use of next-generation sequencing (NGS), including multigene panels and exome and genome sequencing, has led to increased identification of rare and previously unreported variants in Mendelian disorders, though evidence supporting their clinical interpretation remains limited. In Fabry disease (FD), this issue is particularly relevant because the interpretation of individual

Indexed as

Anderson–Fabry diseasegene variantα-galactosidase A

Identifiers

PMID42882116
PMCPMC13666460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.